Elham Bayat

906 total citations
29 papers, 517 citations indexed

About

Elham Bayat is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Elham Bayat has authored 29 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Neurology. Recurrent topics in Elham Bayat's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Elham Bayat is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Elham Bayat collaborates with scholars based in Iran, United States and France. Elham Bayat's co-authors include Justin Kwan, Laura E. Danielian, John A. Butman, Mary Kay Floeter, Suh Young Jeong, Teepu Siddique, Lingye Chen, Peter van Gelderen, Martha Quezado and Han‐Xiang Deng and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

Elham Bayat

28 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Bayat Iran 10 266 110 106 87 82 29 517
Siranush Sargsyan United States 8 179 0.7× 141 1.3× 30 0.3× 98 1.1× 145 1.8× 12 508
Nabeela Nathoo Canada 9 70 0.3× 109 1.0× 84 0.8× 27 0.3× 94 1.1× 36 503
Olivia Hough Canada 8 55 0.2× 114 1.0× 187 1.8× 35 0.4× 96 1.2× 16 681
Zen Kobayashi Japan 11 284 1.1× 127 1.2× 14 0.1× 123 1.4× 89 1.1× 50 434
E. Jerome Hanson United States 7 161 0.6× 56 0.5× 92 0.9× 156 1.8× 62 0.8× 8 465
Giovanna Carrara Italy 6 233 0.9× 54 0.5× 23 0.2× 110 1.3× 44 0.5× 7 460
Qingshan Teng United States 13 222 0.8× 352 3.2× 20 0.2× 129 1.5× 73 0.9× 29 674
Cathleen V. Allen United States 6 77 0.3× 79 0.7× 75 0.7× 100 1.1× 30 0.4× 9 345
Long Vu United States 6 52 0.2× 57 0.5× 79 0.7× 107 1.2× 68 0.8× 10 361
Silvia Bonanno Italy 19 421 1.6× 314 2.9× 18 0.2× 251 2.9× 63 0.8× 40 807

Countries citing papers authored by Elham Bayat

Since Specialization
Citations

This map shows the geographic impact of Elham Bayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Bayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Bayat more than expected).

Fields of papers citing papers by Elham Bayat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Bayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Bayat. The network helps show where Elham Bayat may publish in the future.

Co-authorship network of co-authors of Elham Bayat

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Bayat. A scholar is included among the top collaborators of Elham Bayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Bayat. Elham Bayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esmaeili, Fariba, et al.. (2024). Cetuximab scFv-Modified 5-FU Loaded Chitosan Nanoparticles: "A Novel Therapeutic Platform.". Current Pharmaceutical Biotechnology. 26. 2 indexed citations
2.
Barkhordari, Farzaneh, et al.. (2024). Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells. Scientific Reports. 14(1). 25080–25080. 1 indexed citations
3.
Talebkhan, Yeganeh, Elham Bayat, Alireza Biglari, et al.. (2024). A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic. AMB Express. 14(1). 19–19. 3 indexed citations
4.
Garbey, Marc, et al.. (2024). Improving care for amyotrophic lateral sclerosis with artificial intelligence and affective computing. Journal of the Neurological Sciences. 468. 123328–123328. 1 indexed citations
5.
Gholami, Parisa, Elham Bayat, Yeganeh Talebkhan, et al.. (2023). Expression, Purification, and Biological Evaluation of XTEN-GCSF in a Neutropenic Rat Model. Applied Biochemistry and Biotechnology. 196(2). 804–820. 3 indexed citations
6.
Bayat, Elham, Hooman Aghamirza Moghim Aliabadi, Soroush Sardari, et al.. (2022). Bacterial production and biophysical characterization of a hard-to-fold scFv against myeloid leukemia cell surface marker, IL-1RAP. Molecular Biology Reports. 50(2). 1191–1202. 3 indexed citations
7.
Bayat, Elham, et al.. (2022). Targeted integration in CHO cells using CRIS-PITCh/Bxb1 recombinase–mediated cassette exchange hybrid system. Applied Microbiology and Biotechnology. 107(2-3). 769–783. 6 indexed citations
8.
Bayat, Elham, et al.. (2021). Targeted integration into pseudo attP sites of CHO cells using CRISPR/Cas9. Journal of Biotechnology. 337. 1–7. 10 indexed citations
9.
Bayat, Elham, et al.. (2021). ALS-Like Disorder in Three HIV-Positive Patients: Case Series. Case Reports in Neurology. 13(1). 59–64. 9 indexed citations
10.
Talebkhan, Yeganeh, Fereidoun Mahboudi, Reza Ahangari Cohan, et al.. (2020). Improvement of Certolizumab Fab′ properties by PASylation technology. Scientific Reports. 10(1). 18464–18464. 19 indexed citations
11.
Talebkhan, Yeganeh, Elham Bayat, Fatemeh Torkashvand, et al.. (2020). Optimization of culture conditions for high-level expression of soluble and active tumor necrosis factor-α in E. coli. Protein Expression and Purification. 179. 105805–105805. 6 indexed citations
12.
Karimipoor, Morteza, Fatemeh Davami, Elham Bayat, et al.. (2020). DARPin Ec1-LMWP protein scaffold in targeted delivery of siRNA molecules through EpCAM cancer stem cell marker. Molecular Biology Reports. 47(10). 7323–7331. 6 indexed citations
13.
Shirazi, Farshad H., Yeganeh Talebkhan, Maryam Tabarzad, et al.. (2018). A comparative study of the bispecific monoclonal antibody, blinatumomab expression in CHO cells and E. coli. Preparative Biochemistry & Biotechnology. 48(10). 961–967. 5 indexed citations
14.
Burakgazi, Ahmet Z., et al.. (2014). Underrecognized Anomaly. Journal of Clinical Neurophysiology. 31(1). 31–34. 4 indexed citations
15.
Meoded, Avner, Justin Kwan, Tracy L. Peters, et al.. (2013). Imaging Findings Associated with Cognitive Performance in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis. Dementia and Geriatric Cognitive Disorders. 3(1). 233–250. 20 indexed citations
16.
Kwan, Justin, Suh Young Jeong, Peter van Gelderen, et al.. (2012). Iron Accumulation in Deep Cortical Layers Accounts for MRI Signal Abnormalities in ALS: Correlating 7 Tesla MRI and Pathology. PLoS ONE. 7(4). e35241–e35241. 214 indexed citations
17.
Iwata, N., Justin Kwan, Laura E. Danielian, et al.. (2011). White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain. 134(9). 2642–2655. 100 indexed citations
18.
Amini, Bahram, et al.. (2010). CLONING OF CATALYTIC DOMAIN OF EXOTOXIN A FROM PSEUDOMONAS AERUGINOSA. Journal of Advances in Medical and Biomedical Research. 18(71). 24–33. 5 indexed citations
19.
Bayat, Elham, et al.. (2010). ISOLATION, DETERMINATION AND CLONING OF TRANSLOCATION DOMAIN OF EXOTOXIN A FROM PSEUDOMONAS AERUGINOSA. Trauma Monthly. 15(3). 149–154.
20.
Norris, Lorenzo, et al.. (2010). Psychiatric Aspects of Amyotrophic Lateral Sclerosis (ALS). Current Psychiatry Reports. 12(3). 239–245. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siranush Sargsyan Breakdown of academic impact, for papers by Nabeela Nathoo Breakdown of academic impact, for papers by Olivia Hough Breakdown of academic impact, for papers by Zen Kobayashi Breakdown of academic impact, for papers by E. Jerome Hanson Breakdown of academic impact, for papers by Giovanna Carrara Breakdown of academic impact, for papers by Qingshan Teng Breakdown of academic impact, for papers by Cathleen V. Allen Breakdown of academic impact, for papers by Long Vu Breakdown of academic impact, for papers by Silvia Bonanno
Rankless by CCL
2026